Capital Advisors Inc Beam Therapeutics Inc. Transaction History

Capital Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$36.73 - $51.6 $54,727 - $76,884	-1,490 Reduced 1.36%	108,354 $0
Q3 2022 Oct 17, 2022	BUY	$39.79 - $70.31 $43,689 - $77,200	1,098 Added 1.01%	109,844 $5.23 Million
Q2 2022 Jul 15, 2022	BUY	$29.86 - $62.36 $372,055 - $777,005	12,460 Added 12.94%	108,746 $4.21 Million
Q1 2022 May 05, 2022	BUY	$53.73 - $82.16 $279,342 - $427,149	5,199 Added 5.71%	96,286 $5.52 Million
Q4 2021 Jan 27, 2022	BUY	$68.02 - $99.06 $372,001 - $541,759	5,469 Added 6.39%	91,087 $7.26 Million
Q3 2021 Oct 25, 2021	BUY	$84.37 - $133.6 $223,664 - $354,173	2,651 Added 3.2%	85,618 $7.45 Million
Q2 2021 Aug 02, 2021	BUY	$64.12 - $128.71 $367,664 - $738,023	5,734 Added 7.42%	82,967 $10.7 Million
Q1 2021 May 25, 2021	BUY	$71.28 - $120.75 $5.51 Million - $9.33 Million	77,233 New	77,233 $6.18 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors Inc with notifications on news.